Insights

Innovative Technology Integration Syntekabio's advanced AI-driven drug discovery platform, combined with Next Generation Sequencing and proprietary supercomputing infrastructure, positions it as a leader in cutting-edge biotech solutions. This technology focus opens opportunities for partnerships with pharmaceutical firms seeking to accelerate their R&D pipelines using AI and genomics.

Expanding Global Presence With a strategic US hub in New York and active participation in major industry events like the JP Morgan Healthcare Conference, Syntekabio demonstrates its intent to deepen collaborations with global pharma and biotech companies. This creates potential sales avenues through SaaS offerings and bespoke AI solutions.

Recent Asset Program Launch The recent launch of AI-driven Asset Programs targeting antibody and small-molecule candidates signifies a commitment to expanding their drug discovery pipeline. These initiatives could attract biotech and pharma clients interested in leveraging AI for rapid candidate identification and development.

Strategic Collaborations and Partnerships Partnerships with notable industry players like MetaVia Inc., Enamine Ltd., and Polaris Quantum Biotech highlight Syntekabio's collaborative approach. These alliances suggest opportunities to co-develop AI-powered solutions and expand market reach within the drug discovery ecosystem.

Financial Strength and Growth Potential With a revenue range of $50M to $100M and recent fundraising, Syntekabio is positioned for growth. Its focus on innovative AI technologies and strategic industry collaborations indicates significant potential for sales efforts targeting organizations seeking cutting-edge biotech solutions and AI-enabled drug development services.

Syntekabio Inc. Tech Stack

Syntekabio Inc. uses 8 technology products and services including Amazon Web Services, Unpkg, Google Cloud CDN, and more. Explore Syntekabio Inc.'s tech stack below.

  • Amazon Web Services
    Cloud Hosting
  • Unpkg
    Content Delivery Network
  • Google Cloud CDN
    Content Delivery Network
  • jQuery
    Javascript Libraries
  • X-XSS-Protection
    Security
  • HTTP/3
    Web & Portal Technology
  • X-Content-Type-Options
    Web & Portal Technology
  • Nginx
    Web Servers

Media & News

Syntekabio Inc.'s Email Address Formats

Syntekabio Inc. uses at least 1 format(s):
Syntekabio Inc. Email FormatsExamplePercentage
Last@syntekabio.comDoe@syntekabio.com
52%
First@syntekabio.comJohn@syntekabio.com
34%
FLast@syntekabio.comJDoe@syntekabio.com
9%
First.Last@syntekabio.comJohn.Doe@syntekabio.com
5%

Frequently Asked Questions

Where is Syntekabio Inc.'s headquarters located?

Minus sign iconPlus sign icon
Syntekabio Inc.'s main headquarters is located at 425 5th Avenue Suite 505 New York, New York United States. The company has employees across 2 continents, including North AmericaEurope.

What is Syntekabio Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Syntekabio Inc.'s official website is syntekabio.com and has social profiles on LinkedInCrunchbase.

What is Syntekabio Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Syntekabio Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Syntekabio Inc. have currently?

Minus sign iconPlus sign icon
As of April 2026, Syntekabio Inc. has approximately 38 employees across 2 continents, including North AmericaEurope. Key team members include Chief Executive Officer: J. J.Head Of Ai Center Development Team: M. J. K.Owner: J. J.. Explore Syntekabio Inc.'s employee directory with LeadIQ.

What industry does Syntekabio Inc. belong to?

Minus sign iconPlus sign icon
Syntekabio Inc. operates in the Biotechnology Research industry.

What technology does Syntekabio Inc. use?

Minus sign iconPlus sign icon
Syntekabio Inc.'s tech stack includes Amazon Web ServicesUnpkgGoogle Cloud CDNjQueryX-XSS-ProtectionHTTP/3X-Content-Type-OptionsNginx.

What is Syntekabio Inc.'s email format?

Minus sign iconPlus sign icon
Syntekabio Inc.'s email format typically follows the pattern of Last@syntekabio.com. Find more Syntekabio Inc. email formats with LeadIQ.

How much funding has Syntekabio Inc. raised to date?

Minus sign iconPlus sign icon
As of April 2026, Syntekabio Inc. has raised $7.4M in funding. The last funding round occurred on Apr 03, 2024 for $7.4M.

When was Syntekabio Inc. founded?

Minus sign iconPlus sign icon
Syntekabio Inc. was founded in 2009.

Syntekabio Inc.

Biotechnology ResearchNew York, United States11-50 Employees

Welcome to Syntekabio Inc. – Your Leading AI Drug Discovery and Development Partner

Syntekabio is a pioneering biotech firm headquartered in South Korea, with a vibrant presence in the United States. Our core mission is to redefine the landscape of drug discovery and development by harnessing the transformative potential of Artificial Intelligence (AI) and Next Generation Sequencing (NGS).

At Syntekabio, we merge cutting-edge technologies, boasting a robust genomic database and AI-driven algorithms, with our proprietary supercomputing infrastructure. This synergistic approach empowers us to forecast and pinpoint promising new molecular entities, laying the groundwork for groundbreaking advancements in drug development.

Driven by our commitment to innovation and patient-centric care, Syntekabio is dedicated to delivering novel therapies that extend and enhance lives. We actively seek collaborations with esteemed academic institutions, industrial partners, and government research labs to drive transformative advancements in medicine on a global scale.

Conveniently located in New York City, Syntekabio USA serves as our hub for innovation and collaboration. Visit our website at www.syntekabio.com to explore our cutting-edge AI and NGS-based technologies and join us on our journey to shape the future of healthcare.

"Syntekabio is at the forefront of pioneering AI-driven drug discovery and development initiatives across diverse domains."

Section iconCompany Overview

Headquarters
425 5th Avenue Suite 505 New York, New York United States
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2009
Employees
11-50

Section iconFunding & Financials

  • $7.4M

    Syntekabio Inc. has raised a total of $7.4M of funding over 6 rounds. Their latest funding round was raised on Apr 03, 2024 in the amount of $7.4M.

  • $50M$100M

    Syntekabio Inc.'s revenue is estimated to be in the range of $50M$100M

Section iconFunding & Financials

  • $7.4M

    Syntekabio Inc. has raised a total of $7.4M of funding over 6 rounds. Their latest funding round was raised on Apr 03, 2024 in the amount of $7.4M.

  • $50M$100M

    Syntekabio Inc.'s revenue is estimated to be in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.